95 hasil
Menampilkan 1–20 · 0,31 detik · RSS
International Journal of Diabetes and Technology
ISSN 2949-8457 · Wolters Kluwer Medknow Publications · 95 artikel di indeks
-
Artikel Jurnal
Clinician Insights on Telmisartan - Dapagliflozin Combination Therapy for Cardio-renal-metabolic Risk Management: SYNERGY Survey
Background: Patients with type 2 diabetes mellitus (T2DM) frequently have coexisting hypertension and are at increased risk of cardiovascular (CV) and renal complications. Monotherapy-centric or stepwise treatment approaches may leave substantial residual cardio-renal-metabolic (CRM) risk…
-
Artikel Jurnal
A Two-open-label, Prospective, Multicentric, Phase IV Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride Tablets 500 mg and 1000 mg in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone
Aim: The aim of this study was to evaluate the efficacy, safety, and tolerability of imeglimin hydrochloride tablets as monotherapy in Indian individuals with type 2 diabetes mellitus (T2DM) inadequately controlled by diet and exercise alone. Methods: Two independent, prospective, multicentric…
-
Artikel Jurnal
A Phase III, Randomized, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of a Fixed Dose Combination of Dapagliflozin and Pioglitazone in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin Monotherapy
Background: Fixed-dose combination (FDC) therapy of dapagliflozin and pioglitazone provides a synergistic mechanism of action, potentially improving glycemic control. This study examined the efficacy, safety, and tolerability of a FDC of pioglitazone and dapagliflozin in individuals with type 2…
-
Artikel Jurnal
Modulatory Effects of Rutin on CREM Expression and Testicular Histomorphology in Streptozotocin-Induced Type 2 Diabetic Wistar Rats
Objectives: Male infertility is often exacerbated by testicular toxicity associated with the diabetic inducing potency of Streptozotocin (STZ) in Wistar rats, which damages testicular tissues and represses cyclic AMP response element modulator (CREM) gene expression through proinflammatory and…
-
Artikel Jurnal
Mobile Health Applications for Type 2 Diabetes Remission and Weight Management: A Position Statement on Efficacy, Regulation, and Ethical Implementation
Chronic metabolic diseases such as type 2 diabetes (T2D) and obesity remain major global health challenges, driven by impaired energy regulation, insulin resistance, and systemic inflammation. Traditional treatment paradigms emphasize symptom control, whereas emerging strategies target the root…
-
Artikel Jurnal
The NEUROSARC-EG Study: Prevalence and Clinical Correlates of Sarcopenia in Egyptian Patients with Type 2 Diabetes and Diabetic Neuropathy – A Cross-sectional Epidemiological Study
Background and Aim: The progressive loss of strength and muscle mass, known as sarcopenia, can negatively affect a person’s metabolic health and is a syndrome that is increasingly recognized. Sarcopenia is known to be associated with type 2 diabetes mellitus (T2DM) and its complications, but data…
-
Artikel Jurnal
Should Dengue Vaccination be Prioritized in Individuals with Diabetes?
Type 2 diabetes (T2D) is a rapidly expanding global health challenge that heightens vulnerability to infections, including dengue, the most widespread mosquito-borne viral disease worldwide. Emerging evidence indicates that individuals with T2D are at increased risk of severe dengue manifestations…
-
Artikel Jurnal
When Pain Cannot Warn: Catastrophic Fournier’s Gangrene in a Patient with Perineal Neuropathy on Canagliflozin
Fournier’s gangrene is a life-threatening necrotizing fasciitis of the genitoperineal region with 20%–40% mortality despite aggressive treatment. While SGLT2 inhibitors are associated with this condition, extensive scrotal involvement developing rapidly remains uncommonly reported. We present a…
-
Artikel Jurnal
Intermittent Use of Flash Glucose Monitoring as a Useful Tool for Patients with Type 1 Diabetes in Developing Countries
Background and Aims: The cost of flash glucose monitoring (FGM) has been the principal barrier to treating type 1 diabetes (T1D) in developing nations; this study evaluates the efficiency of an intermittent scanning regimen on improving glycemic outcomes and preventing acute diabetic complications…
-
Artikel Jurnal
Glycemic Variability as a Temporal Dimension of Intrauterine Glucose Exposure in Addition to Glycated Hemoglobin: Associations with Fetal Neurometabolic Outcomes – A Systematic Review
Although glycated hemoglobin (HbA1c) remains the principal marker of glycemic control in pregnancy, adverse fetal and neonatal outcomes are still observed in pregnancies considered well controlled by conventional thresholds. This observation has prompted reconsideration of whether averaged glycemia…
-
Artikel Jurnal
Ethical and Legal Implications for the Use of Artificial Intelligence and Telemedicine in Healthcare in India: The Past, Present, and Future Directions
Through improved access to specialist services, streamlined treatment procedures, and increased diagnostic accuracy, the swift integration of telemedicine and artificial intelligence (AI) in India’s healthcare system has revolutionized patient care. The key areas of application include AI-assisted…
-
Artikel Jurnal
Optimizing the Use of Continuous Glucose Monitoring in People with Type 2 Diabetes on Noninsulin-based Regimens: A Case Series with Narrative Review and Expert Opinion
The use of continuous glucose monitoring (CGM) results in better glycemic control compared with self-monitoring of blood glucose in people with type 2 diabetes (T2D) on noninsulin regimens. However, real-world evidence is limited because CGM is often not reimbursed in this population in Asia…
-
Artikel Jurnal
Taking a Closer Look at Gliclazide – Benefits Beyond Glycemic Control
The increasing prevalence of type 2 diabetes mellitus (T2DM) and the associated challenges in treatment are a cause of concern worldwide. Gliclazide is an oral antidiabetes drug used in the treatment of T2DM. It is a second-generation sulphonylurea (SU) which controls blood glucose levels and…
-
Artikel Jurnal
Characterization of Treatment Intensified (Add-on to Metformin) Adults with Type 2 Diabetes: Real-world Clinical Experience (Cardiovascular Outcomes and Value in the Real-world with Glucagon-like Peptide-1 Receptor Agonists) from India in 2008 to 2017
Objective: The cardiovascular outcomes and value in the real world with GLP-1 receptor agonists study characterized demographics and medication usage patterns in treatment intensified (add-on to metformin) adults with type 2 diabetes (T2D) in India. Materials and Methods: This study was a…
-
Artikel Jurnal
Generative Artificial Intelligence and its Leap into Diabetes Management
Artificial intelligence (AI) has transitioned from theoretical explorations to a transformative force driving innovation across multiple industries. Generative AI, a specialized subset, showcases exceptional capabilities in generating content, such as text, images, and music, and solving complex…
-
Artikel Jurnal
Comparison of Two Short-acting Insulin Formulations in the Management of Blood Glucose in Undergoing Coronary Artery Bypass Graft Surgery Patients
Background: Postoperative high blood glucose levels can affect the prognosis following coronary artery bypass graft (CABG). Although actrapid and fast-acting insulin aspart (FIASP) are approved for intravenous (IV) use, very limited data on their safety and efficacy in patients undergoing cardiac…